SCHEMBL25481828

SCHEMBL25481828

C[C@@H]1CCCCCN1c1ccnc(N)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 3/20 0.50
▸ HRH4 Q9H3N8 1/20 0.48
▸ SMPD3 Q9NY59 1/20 0.47
▸ PDPK1 O15530 1/20 0.46
▸ TGFBR1 P36897 1/20 0.46
▸ AURKB Q96GD4 1/20 0.46
▸ ROCK1 Q13464 6/20 0.46
▸ PIM1 P11309 2/20 0.45
▸ PIM3 Q86V86 2/20 0.45
▸ PIM2 Q9P1W9 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CHRM4 P08173 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ JAK3 P52333 1/20 0.42
▸ BCHE P06276 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25481832 1.00 HRH3 (0.50) HRH3HRH4SMPD3PDPK1TGFBR1
SCHEMBL25481443 1.00 HRH3 (0.50) HRH3HRH4SMPD3PDPK1TGFBR1
SCHEMBL12615103 0.81 BCHE (0.43) SMPD3PIM1PIM3PIM2KDM4E
SCHEMBL12185048 0.81 BCHE (0.43) SMPD3PIM1PIM3PIM2KDM4E
SCHEMBL22616998 0.77 HRH3 (0.48) HRH3HRH4ROCK1
SCHEMBL14890430 0.76 ASIC3 (0.49) SMPD3PDPK1TGFBR1AURKBPIM1
SCHEMBL6628274 0.75 SMPD3 (0.48) SMPD3PDPK1TGFBR1AURKBKDM4E
SCHEMBL10932400 0.74 HRH3 (0.69) HRH3HRH4SMPD3ROCK1HTT
SCHEMBL3717623 0.73 PDPK1 (0.52) HRH4SMPD3PDPK1TGFBR1AURKB
SCHEMBL27099909 0.73 GFER (0.47) SMPD3PDPK1TGFBR1AURKBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150993-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150993-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MKI67, MCL1, CCNI HRH3 4118/4885HRH4 4030/4885SMPD3 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback